Table of Contents:
  • Spontaneous reporting systems: benefits and pitfalls when interpreting safety data of non-steroidal anti-inflammatory drugs / B.-E. Wiholm
  • Drug utilization studies: a useful tool for the safety evaluation of non-steroidal anti-inflammatory drugs? / P.K.M. Lunde
  • Post-marketing surveillance as an instrument of adverse drug reaction monitoring / H. Kewitz
  • Non-steroidal anti-inflammatory drugs: epidemiological studies of adverse reactions / M. Levy
  • SPALA project: an intensive monitoring system for non-steroidal anti-inflammatory drugs / SPALA project team
  • Toxicity analysis of mild analgesics in clinical use / E. Weber
  • Gastrointestinal tract toxicity: a risk factor for non-steroidal anti-inflammatory drugs therapy / C.J. Hawkey
  • Incidence of mild and severe skin reactions associated with the use on non-steroidal anti-inflammatory drugs / E. Schopf and B. Rzany
  • Kidney function impairment: do relevant differences between non-steroidal anti-inflammatory drugs exitst? / J. Mann and M. Goerig.